3 ms·
My research indicated that the median broad-scale vaccine phase III trial is about 22,000 people [1]. I've also seen the 3,000 to 6,000 person range for smaller
by arcticbull 6y ago
My research indicated that the median broad-scale vaccine phase III trial is about 22,000 people [1]. I've also seen the 3,000 to 6,000 person range for smaller trials [2].
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551877/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551877/
[2] https://www.theatlantic.com/health/archive/2020/10/what-successful-vaccine-trial-looks-like/616775/ https://www.theatlantic.com/health/archive/2020/10/what-succ...
- dehrmann 6y agoI can't seem to find it, but I remember reading that vaccine researchers hold their breaths until 1M people have had it for 8 weeks. In normal times, the J&J vaccine would probably be taken off the market or only recommended for men.